|
Home
Page
Forum
Bella Mira
Perfect Complexion
Bella Mira Essential Oil
Supplements
Bella Mira Magnetic Hair Care
Essential Oil Information and Use
Essential Oil
Singles
Essential Oil
Blends
Essential Oil
Kits
Essential Oil Supplies
Chemical Free Body Care Products
Chemical Free Cleaning Products
Gluten Free Living and Recipes
Gluten Free Products

Thyroid 101
Fibromyalgia 101
PAIN Relief and Information
Detoxification and Digestion Products
Pet Place
CD's DVD's and Books
Save Your Computer Free Protection
Kelp, Ear Candles and More
Woman's World
CD's DVD's and Books
3-D Screensavers
Hormone Balance Test New
Improved
Thyroid Function Test
Internal Toxicity Test

Gift Certificates
Link Exchange/Banners
(918)
640-2973

Our
Shopping Cart Is:

& FAQ

Free Samples w/$100 Order.


| |
GSK petition threatens weight loss supplements 5-18-08
Many may not have known this: GlaxoSimthKline (GSK) on April 17, 2008 submitted
its 33-page petition to the FDA asking the agency to consider weight loss claims
for dietary supplements as disease claims.
This petition means that the FDA should consider overweight and obesity as
disease. When a condition is considered as a disease, dietary supplements should
have no health claims on such a disease. Under the FDA regulation, dietary
supplements can't be claimed to have any effect on any disease. In effect, this
regulation prevents dietary supplements from competing with drugs.
GSK is the manufacturer of Alli, the first over-the-counter weight loss drug,
which the Public Citizen said is not effective enough for the FDA to approve its
sales in the United States. The FDA approved Alli for over-the-counter sales on
Feb 17, 2007.
Supplementinfo.org has posted a message on its website saying that "This may
have huge implications for not only the supplement weight loss industry, which
is rapidly growing and estimated to currently be worth $1.3 billion in annual
sales, but for the dietary supplements industry overall; some see it as another
step in the overregulation of dietary supplements and attacks from big pharma,
which, should FDA decide to rule in favor of GSK, some say could be a death
knell for our industry."
|